Global Eosinophilic Esophagitis Drug Competitive Landscape Professional Research Report 2025
Research Summary
Eosinophilic esophagitis (EoE) drugs are pharmaceutical treatments designed to manage the symptoms and underlying inflammation associated with EoE, a chronic inflammatory disorder of the esophagus characterized by an excessive number of eosinophils in the esophageal tissue. Common EoE drugs include proton pump inhibitors (PPIs) to address acid reflux-related triggers, swallowed corticosteroids like fluticasone or budesonide to reduce esophageal inflammation, and biologic therapies, such as monoclonal antibodies like dupilumab, which can target specific immune pathways involved in EoE. The choice of EoE drug depends on the severity of the condition, the individual＇s response to treatment, and other specific factors, with the ultimate goal of alleviating symptoms, preventing complications like esophageal strictures, and improving the overall quality of life for EoE patients.
According to DIResearch's in-depth investigation and research, the global Eosinophilic Esophagitis Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Eosinophilic Esophagitis Drug include AstraZeneca, GSK, Bayer, Adare Pharmaceuticals, DBV Technologies, Dr. Falk Pharma, Quorum Innovations, Takeda, Calypso, Regeneron, Celgene etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Eosinophilic Esophagitis Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Eosinophilic Esophagitis Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Eosinophilic Esophagitis Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Eosinophilic Esophagitis Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Eosinophilic Esophagitis Drug Include:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Regeneron
Celgene
Eosinophilic Esophagitis Drug Product Segment Include:
Budesonide
Fluticasone
Others
Eosinophilic Esophagitis Drug Product Application Include:
Hospitals
Clinics
Drugstore
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Eosinophilic Esophagitis Drug Industry PESTEL Analysis
Chapter 3: Global Eosinophilic Esophagitis Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Eosinophilic Esophagitis Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Eosinophilic Esophagitis Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Eosinophilic Esophagitis Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Eosinophilic Esophagitis Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Eosinophilic Esophagitis Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Eosinophilic Esophagitis Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Eosinophilic Esophagitis Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Eosinophilic Esophagitis Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Eosinophilic Esophagitis Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Eosinophilic Esophagitis Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Eosinophilic Esophagitis Drug Product by Type
- 1.2.1 Budesonide
- 1.2.2 Fluticasone
- 1.2.3 Others
- 1.3 Eosinophilic Esophagitis Drug Product by Application
- 1.3.1 Hospitals
- 1.3.2 Clinics
- 1.3.3 Drugstore
- 1.4 Global Eosinophilic Esophagitis Drug Market Size Analysis (2020-2032)
- 1.5 Eosinophilic Esophagitis Drug Market Development Status and Trends
- 1.5.1 Eosinophilic Esophagitis Drug Industry Development Status Analysis
- 1.5.2 Eosinophilic Esophagitis Drug Industry Development Trends Analysis
- 2 Eosinophilic Esophagitis Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Eosinophilic Esophagitis Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Eosinophilic Esophagitis Drug Market Analysis by Regions
- 4.1 Eosinophilic Esophagitis Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Eosinophilic Esophagitis Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2032)
- 5 Global Eosinophilic Esophagitis Drug Market Size by Type and Application
- 5.1 Global Eosinophilic Esophagitis Drug Market Size by Type (2020-2032)
- 5.2 Global Eosinophilic Esophagitis Drug Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Eosinophilic Esophagitis Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Eosinophilic Esophagitis Drug Market Size by Type
- 6.4 North America Eosinophilic Esophagitis Drug Market Size by Application
- 6.5 North America Eosinophilic Esophagitis Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Eosinophilic Esophagitis Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Eosinophilic Esophagitis Drug Market Size by Type
- 7.4 Europe Eosinophilic Esophagitis Drug Market Size by Application
- 7.5 Europe Eosinophilic Esophagitis Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Eosinophilic Esophagitis Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Eosinophilic Esophagitis Drug Market Size by Type
- 8.4 China Eosinophilic Esophagitis Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Eosinophilic Esophagitis Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Eosinophilic Esophagitis Drug Market Size by Type
- 9.4 APAC (excl. China) Eosinophilic Esophagitis Drug Market Size by Application
- 9.5 APAC (excl. China) Eosinophilic Esophagitis Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Eosinophilic Esophagitis Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Eosinophilic Esophagitis Drug Market Size by Type
- 10.4 Latin America Eosinophilic Esophagitis Drug Market Size by Application
- 10.5 Latin America Eosinophilic Esophagitis Drug Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Eosinophilic Esophagitis Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Eosinophilic Esophagitis Drug Market Size by Type
- 11.4 Middle East & Africa Eosinophilic Esophagitis Drug Market Size by Application
- 11.5 Middle East & Africa Eosinophilic Esophagitis Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Eosinophilic Esophagitis Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Eosinophilic Esophagitis Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Eosinophilic Esophagitis Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AstraZeneca
- 13.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AstraZeneca Eosinophilic Esophagitis Drug Product Portfolio
- 13.1.3 AstraZeneca Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 GSK
- 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GSK Eosinophilic Esophagitis Drug Product Portfolio
- 13.2.3 GSK Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Bayer
- 13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bayer Eosinophilic Esophagitis Drug Product Portfolio
- 13.3.3 Bayer Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Adare Pharmaceuticals
- 13.4.1 Adare Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolio
- 13.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 DBV Technologies
- 13.5.1 DBV Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 DBV Technologies Eosinophilic Esophagitis Drug Product Portfolio
- 13.5.3 DBV Technologies Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Dr. Falk Pharma
- 13.6.1 Dr. Falk Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolio
- 13.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Quorum Innovations
- 13.7.1 Quorum Innovations Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolio
- 13.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Takeda
- 13.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Takeda Eosinophilic Esophagitis Drug Product Portfolio
- 13.8.3 Takeda Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Calypso
- 13.9.1 Calypso Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Calypso Eosinophilic Esophagitis Drug Product Portfolio
- 13.9.3 Calypso Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Regeneron
- 13.10.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Regeneron Eosinophilic Esophagitis Drug Product Portfolio
- 13.10.3 Regeneron Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Celgene
- 13.11.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Celgene Eosinophilic Esophagitis Drug Product Portfolio
- 13.11.3 Celgene Eosinophilic Esophagitis Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Eosinophilic Esophagitis Drug Industry Chain Analysis
- 14.2 Eosinophilic Esophagitis Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Eosinophilic Esophagitis Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Eosinophilic Esophagitis Drug Typical Downstream Customers
- 14.4 Eosinophilic Esophagitis Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook